Medicube is not a small indie label. Here is who owns it, how big it got, and what that means when you buy.
Seoul, starting with the Aprilskin brand.
Cheap, high-repeat products, most famously the Zero Pore pads.
Roughly 50,000 units in the first year, and a much higher margin than pads.
Debut jumped 27%, valuing the company near US $1.8bn.
Up 111% on the year, with 80% earned outside Korea.
Cumulative Age-R sales pass six million units in January.
About US $1.05bn, up 111% year on year, at a 24% operating margin. Source: APR Corp.
KRW 1.23tn of the 2025 total, up 207% year on year. Source: APR Corp.
As of January 2026, up from roughly 50,000 in the first year. Source: APR Corp.
APR reports the beauty devices at KRW 407bn of KRW 1.53tn, which is roughly 27% by our arithmetic. They are the high-margin part of the business, not the big part.
We have not tested these products. We read the published ingredient list, summarize what buyers praised and criticized, and say plainly when to skip.
Read the full brand story